`
`https://www.wsj.com/articles/valeant-rebuffs-critical-report-that-pummel...
`
`▼
`
`▼
`
`▼
`
`▲
`
`▲
`
`▲
`
`This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit
`http://www.djreprints.com.
`
`http://www.wsj.com/articles/valeant-rebuffs-critical-report-that-pummels-stock-1445452695
`
`The Valeant headquarters in Laval, Quebec. PHOTO: REUTERS
`
`▲
`
`1 of 3
`
`10/30/2017, 3:41 PM
`
`Page 1 of 3
`
`ACRUX DDS PTY LTD. et al.
`
`EXHIBIT 1545
`
`IPR Petition for
`
`U.S. Patent No. 7,214,506
`
`
`
`Valeant Slumps Again After Rebutting Critical Report - WSJ
`
`https://www.wsj.com/articles/valeant-rebuffs-critical-report-that-pummel...
`
`RELATED
`
`Heard on the Street: Feeling Valeant? Don’t Rush In
`Stocks Hurt by Health-Care Losses
`Allergan Responds to Specialty-Pharmacy Concerns
`Valeant Pharmaceuticals Under Investigation by Federal Prosecutors (Oct.15)
`Wall Street Analysts Line Up Behind Valeant as Its Stock Craters (Oct. 20)
`Valeant, Under Pressure About Price Increases, Plans Changes (Oct. 20)
`
`2 of 3
`
`10/30/2017, 3:41 PM
`
`Page 2 of 3
`
`
`
`Valeant Slumps Again After Rebutting Critical Report - WSJ
`
`https://www.wsj.com/articles/valeant-rebuffs-critical-report-that-pummel...
`
`Activist Investor Report Card
`
`Copyright ©2017 Dow Jones & Company, Inc. All Rights Reserved
`
`This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit
`http://www.djreprints.com.
`
`3 of 3
`
`10/30/2017, 3:41 PM
`
`Page 3 of 3
`
`